P2Y12 antagonists (AstraZeneca)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameP2Y12 antagonists (AstraZeneca)
Drug Alias Nameoral P2T purinoceptor antagonists (AstraZeneca)P2T antagonists (AstraZeneca)AR-C118537XXAZ-11931285AR-C120215XX +[7] 
ClassificationSmall molecules
Mechanisms of ActionPlatelet aggregation inhibitorsPurinergic receptor P2Y12 antagonists
TargetsPurinergic receptor P2Y12
Therapy Area/IndicationsThrombosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAstrazeneca Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAstrazeneca Plc
Active IndicationsN/A
Inactive IndicationsThrombosis

Other Information

ATC CodeN/A
Related LinksN/A